New clues why gold standard treatment for bipolar disorder doesn't work for majority of patients

(Salk Institute) Lithium is considered the gold standard for treating bipolar disorder (BD), but nearly 70 percent of people with BD don't respond to it. This leaves them at risk for debilitating, potentially life-threatening mood swings. Researchers at the Salk Institute have found that the culprit may lie in gene activity--or lack of it.

https://www.eurekalert.org/pub_releases/2021-01/si-ncw010421.php

Source: EurekAlert! - Social and Behavioral Science - January 5, 2021 Category: International Medicine & Public Health Source Type: news